//
Otsuka Patient Assistance Foundation Inc. is a private corporation based in PRINCETON, NJ. The foundation received its IRS ruling in 2017. It holds total assets of $72.2M. Annual income is reported at $401.9M. THE OTSUKA ASSISTANCE FOUNDATION, INC. ("FOUNDATION") PROVIDES PHARMACEUTICAL PRODUCTS FREE OF CHARGE TO PATIENTS IN NEED. SPECIFICALLY, THE FOUNDATION OPERATES THE OTSUKA PATIENT ASSISTANCE PROGRAM, WHICH WILL SERVE PATIENTS IN NEED WHO HAVE BEEN PRESCRIBED PHARMACEUTICAL PRODUCTS THAT ARE MARKED OR DISTRIBUTED BY OTSUKA AMERICA PHARMACEUTICAL, INC. AND ITS AFFILIATES. THE FOUNDATION MEETS THE PHARMACEUTICAL NEEDS OF SUCH PATIENTS PRIMARILY THROUGH PRODUCT DONATION AND, WHERE PRACTICAL, BY EDUCATING PATIENTS REGARDING APPLICABLE RESOURCES THAT THEY MAY UTILIZE. DURING 2021, THE FOUNDATION PROVIDED $180,167,180 OF DONATED PRODUCTS TO 13,506 PATIENTS. According to available records, Otsuka Patient Assistance Foundation Inc. has made 3 grants totaling $716.8M, with a median grant of $218.6M. Annual giving has decreased from $437.1M in 2022 to $279.7M in 2023. Individual grants have ranged from $218.6M to $279.7M, with an average award of $238.9M. Grant recipients are concentrated in New Jersey. Contributions to this foundation are tax-deductible.
THE OTSUKA ASSISTANCE FOUNDATION, INC. ("FOUNDATION") PROVIDES PHARMACEUTICAL PRODUCTS FREE OF CHARGE TO PATIENTS IN NEED. SPECIFICALLY, THE FOUNDATION OPERATES THE OTSUKA PATIENT ASSISTANCE PROGRAM, WHICH WILL SERVE PATIENTS IN NEED WHO HAVE BEEN PRESCRIBED PHARMACEUTICAL PRODUCTS THAT ARE MARKED OR DISTRIBUTED BY OTSUKA AMERICA PHARMACEUTICAL, INC. AND ITS AFFILIATES. THE FOUNDATION MEETS THE PHARMACEUTICAL NEEDS OF SUCH PATIENTS PRIMARILY THROUGH PRODUCT DONATION AND, WHERE PRACTICAL, BY EDUCATING PATIENTS REGARDING APPLICABLE RESOURCES THAT THEY MAY UTILIZE. DURING 2020, THE FOUNDATION PROVIDED $168,380,181 OF DONATED PRODUCTS TO 9,067 PATIENTS.
Expenses: $168.4M
THE OTSUKA ASSISTANCE FOUNDATION, INC. ("FOUNDATION") PROVIDES PHARMACEUTICAL PRODUCTS FREE OF CHARGE TO PATIENTS IN NEED. SPECIFICALLY, THE FOUNDATION OPERATES THE OTSUKA PATIENT ASSISTANCE PROGRAM, WHICH WILL SERVE PATIENTS IN NEED WHO HAVE BEEN PRESCRIBED PHARMACEUTICAL PRODUCTS THAT ARE MARKED OR DISTRIBUTED BY OTSUKA AMERICA PHARMACEUTICAL, INC. AND ITS AFFILIATES. THE FOUNDATION MEETS THE PHARMACEUTICAL NEEDS OF SUCH PATIENTS PRIMARILY THROUGH PRODUCT DONATION AND, WHERE PRACTICAL, BY EDUCATING PATIENTS REGARDING APPLICABLE RESOURCES THAT THEY MAY UTILIZE. DURING 2021, THE FOUNDATION PROVIDED $180,167,180 OF DONATED PRODUCTS TO 13,506 PATIENTS. Based on available records, the foundation has funded 3 grants. Its grantmaking reaches organizations primarily in NJ.
Otsuka Patient Assistance Foundation Inc. has distributed a total of $716.8M across 3 grants. The median grant size is $218.6M, with an average of $238.9M. Individual grants have ranged from $218.6M to $279.7M.
Otsuka Patient Assistance Foundation Inc. is a private foundation. To inquire about grants, you can look up the foundation using their EIN (814571545) on GuideStar or contact them directly. Many private foundations have specific application processes that may not be publicly listed.
Otsuka Patient Assistance Foundation Inc. is headquartered in PRINCETON, NJ.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Ashlee Hamilton | ASSISTANT SECRETARY | $0 | $0 | $0 |
| Kenneth Wright | TREASURER | $0 | $0 | $0 |
| Christina Van Derveer | SECRETARY | $0 | $0 | $0 |
| Mark Hoffman | BOARD MEMBER | $0 | $0 | $0 |
| Beth Harper | BOARD MEMBER | $0 | $0 | $0 |
Total Giving
$316.8M
Total Assets
$31.1M
Fair Market Value
$31.1M
Net Worth
$29.5M
Grants Paid
$279.7M
Contributions
$313M
Net Investment Income
$200K
Distribution Amount
$0
Total Grants
3
Total Giving
$716.8M
Average Grant
$238.9M
Median Grant
$218.6M
Unique Recipients
1
Most Common Grant
$218.6M
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Individual Patient ProgramsPROVIDING PHARMACEUTICAL PRODUCTS FREE OF CHARGE TO ELIGIBLE PATIENTS | Princeton, NJ | $279.7M | 2023 |
WHIPPANY, NJ
KESWICK, VA
PROSPECT, KY
NEW BRUNSWICK, NJ
SUNNYVALE, CA
| Kenneth Getz |
| PRESIDENT & DIRECTOR |
| $0 |
| $0 |
| $0 |
| Rachel Thorpe | ASSOCIATE DIRECTOR | $0 | $0 | $0 |
| Terri Hinkley | BOARD MEMBER | $0 | $0 | $0 |
| 2019 | 990PF | View |
| 2018 | 990PF | View |
| 2017 | 990PF | View |
© 2026 Granted AI